1. Home
  2. STNE vs ACAD Comparison

STNE vs ACAD Comparison

Compare STNE & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STNE
  • ACAD
  • Stock Information
  • Founded
  • STNE 2012
  • ACAD 1993
  • Country
  • STNE Cayman Islands
  • ACAD United States
  • Employees
  • STNE N/A
  • ACAD N/A
  • Industry
  • STNE EDP Services
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • STNE Technology
  • ACAD Health Care
  • Exchange
  • STNE Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • STNE 3.5B
  • ACAD 2.9B
  • IPO Year
  • STNE 2018
  • ACAD 2004
  • Fundamental
  • Price
  • STNE $8.20
  • ACAD $16.68
  • Analyst Decision
  • STNE Buy
  • ACAD Buy
  • Analyst Count
  • STNE 10
  • ACAD 18
  • Target Price
  • STNE $16.90
  • ACAD $26.53
  • AVG Volume (30 Days)
  • STNE 7.3M
  • ACAD 1.7M
  • Earning Date
  • STNE 11-12-2024
  • ACAD 11-06-2024
  • Dividend Yield
  • STNE N/A
  • ACAD N/A
  • EPS Growth
  • STNE 103.39
  • ACAD N/A
  • EPS
  • STNE 1.18
  • ACAD 0.78
  • Revenue
  • STNE $2,267,378,982.00
  • ACAD $929,236,000.00
  • Revenue This Year
  • STNE $19.88
  • ACAD $37.34
  • Revenue Next Year
  • STNE $11.72
  • ACAD $7.25
  • P/E Ratio
  • STNE $6.95
  • ACAD $21.73
  • Revenue Growth
  • STNE 13.89
  • ACAD 47.06
  • 52 Week Low
  • STNE $7.89
  • ACAD $14.15
  • 52 Week High
  • STNE $19.46
  • ACAD $32.59
  • Technical
  • Relative Strength Index (RSI)
  • STNE 31.11
  • ACAD 48.24
  • Support Level
  • STNE $9.08
  • ACAD $16.27
  • Resistance Level
  • STNE $9.39
  • ACAD $17.86
  • Average True Range (ATR)
  • STNE 0.38
  • ACAD 0.78
  • MACD
  • STNE -0.08
  • ACAD -0.13
  • Stochastic Oscillator
  • STNE 16.40
  • ACAD 20.62

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs great solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services offers payments, digital banking, and credit solutions, focusing Ton solution mainly on micro-merchants, and Stone solution on SMBs. In Software, it offers POS and ERP solutions for different retail and services verticals, Customer Relationship Management, engagement tools, e-commerce, and Order Management System solutions, among others.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Share on Social Networks: